FDA NDC Directory · JSON-LD · Markdown

Nevirapine

NDC 0378-4050 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namenevirapine
Labeler / ManufacturerMylan Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202523
Dosage form / routeTABLET · ORAL
Active ingredientsNEVIRAPINE (200 mg/1)
Marketing started20120522
Package count1

External sources

Source: openFDA. Public-domain (CC0).